New scientific communication on UTIPRO® PLUS
Following the publication of the experimental study by Fraile B et al. “Xyloglucan, hibiscus and propolis for the prevention of urinary tract infections: results of
New partnership: Xilaplus® AF in Turkey
New partnership: Xilaplus® AF in Turkey Noventure is delighted to announce its new partnership with Generica İlaç to market Noventure’s Xilaplus® AF in Turkey. Xilaplus®
Management of acute diarrhoea
Annamaria Staiano Italian Journal of Pediatrics 2017, 43(Suppl 1): A2 Diarrhoea in children still has a major impact on health-related social costs, affecting approximately 2
Irritable Bowel Syndrome
Ford et al. N Engl J Med 2017; 376:2566-78 New article in NEJM supports the role of increased intestinal permeability in the pathophysiology of IBS.
Noventure’s participation to 2017 EAU
European Association of Urology – London 25th – 27th March 2017. More than 10.300 total participants, coming from 113 countries all over the world. Out
Corporate Press Release: Noventure and RFSU enter into agreement to commercialize Utipro® Plus across Nordic countries.
Barcelona, March 13, 2017 – Noventure and Riksförbundet för sexuell upplysning (RFSU), the Swedish Association for Sexuality Education, announce today that they have entered into
Effect of Utipro® (containing xyloglucan-gelatin) against Escherichia coli invasion of intestinal epithelial cells: results of an in vitro study.
De Servi B et al. Future Microbiology. Published on line: 29 March 2016 Aim: To evaluate whether Utipro(®), a natural product approved to prevent urinary
Undissociated Gelatine Tannate reduces intestinal leakiness and mucosa inflammation by forming a protective biofilm: results from in-vitro and in-vivo studies.
L. Bueno et al. UEG Journal – United European Gastroenterology Journal, Oct.2013: Vol. 1, Supl. 1; ISSN 2050-6406 (print) ISSN 2050-6414 (online) – Pags A75-A76 Introduction:
New insights into the mechanism of action of gelatine tannate for acute diarrhoea. Part 1: film-forming effect.
Freli V. et al. Presented at GFHGHP 2012. Presented as oral communication at the 33rd edition of the Congress from the Groupe Francophone d’Hépato-Gastroentérologie et
Intestinal goblet cells and mucins in health and disease: recent insights and progress.
Kim YS, Ho SB. Curr Gastroenterol Rep. 2010 Oct;12(5):319-30 The mucus layer coating the gastrointestinal tract is the front line of innate host defense, largely
Let's meet in ...
2026, Oct 6-8th
CPHI 2026
2026, June 24
